65 results
8-K
EX-10.1
VANI
Vivani Medical Inc
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
(mm) U.S. Real Property Holding Corporation. The Company
8-K
VANI
Vivani Medical Inc
10 Jan 24
Other Events
4:30pm
, Vivani Medical, Inc. (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq
8-K
xqj17xa1vkqd3o
27 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
DEFR14A
7j7jo78wilxlpghj3gz
1 May 23
Revised proxy
4:49pm
8-K
EX-10.1
u6ng 83m2l2
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm
8-K
lmy94ovlf2 340
2 Sep 22
Entry into a Material Definitive Agreement
3:42pm
425
EX-99.1
nto6i 9cnkgpdaom070c
29 Jul 22
Business combination disclosure
9:07am
8-K
EX-99.1
qar mouvk49qp
29 Jul 22
Submission of Matters to a Vote of Security Holders
9:05am
DEFA14A
yh6hcj sxn8
18 Jul 22
Additional proxy soliciting materials
8:47am
425
EX-99.1
dl9ib6edmv2l7qc
18 Jul 22
Business combination disclosure
8:45am
8-K
EX-99.1
9f8 r8x1tcvmt
18 Jul 22
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
8:44am
DEFM14A
0ob0zzc s6dz11
24 Jun 22
Proxy related to merger
4:44pm
424B3
nxu6l3tlxz81 n7i
24 Jun 22
Prospectus supplement
4:38pm
425
d9dvd
21 Jun 22
Business combination disclosure
4:03pm